Style | Citing Format |
---|---|
MLA | Golchin A, Niknejad H. "Cell Therapy Using Embryonic Stem Cell Source in Clinical Trial Studies: Advantages and Limitations." Journal of Mazandaran University of Medical Sciences, vol. 27, no. 148, 2017, pp. 166-180. |
APA | Golchin A, Niknejad H (2017). Cell Therapy Using Embryonic Stem Cell Source in Clinical Trial Studies: Advantages and Limitations. Journal of Mazandaran University of Medical Sciences, 27(148), 166-180. |
Chicago | Golchin A, Niknejad H. "Cell Therapy Using Embryonic Stem Cell Source in Clinical Trial Studies: Advantages and Limitations." Journal of Mazandaran University of Medical Sciences 27, no. 148 (2017): 166-180. |
Harvard | Golchin A, Niknejad H (2017) 'Cell Therapy Using Embryonic Stem Cell Source in Clinical Trial Studies: Advantages and Limitations', Journal of Mazandaran University of Medical Sciences, 27(148), pp. 166-180. |
Vancouver | Golchin A, Niknejad H. Cell Therapy Using Embryonic Stem Cell Source in Clinical Trial Studies: Advantages and Limitations. Journal of Mazandaran University of Medical Sciences. 2017;27(148):166-180. |
BibTex | @article{ author = {Golchin A and Niknejad H}, title = {Cell Therapy Using Embryonic Stem Cell Source in Clinical Trial Studies: Advantages and Limitations}, journal = {Journal of Mazandaran University of Medical Sciences}, volume = {27}, number = {148}, pages = {166-180}, year = {2017} } |
RIS | TY - JOUR AU - Golchin A AU - Niknejad H TI - Cell Therapy Using Embryonic Stem Cell Source in Clinical Trial Studies: Advantages and Limitations JO - Journal of Mazandaran University of Medical Sciences VL - 27 IS - 148 SP - 166 EP - 180 PY - 2017 ER - |